Evidence map›Paper›PMID 38232913›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2024

Inter-alpha-trypsin inhibitor (IαI) and hyaluronan modifications enhance the innate immune response to influenza virus in the lung.

Fengying Tang, Stephen R Reeves, Jourdan E Brune, Mary Y Chang, Christina K Chan, Peter Waldron, Sheona P Drummond, Caroline M Milner, Kimberly M Alonge, Stavros Garantziotis and 3 more

Abstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Hyaluronan Is a Promising Host-directed Therapy for Viral Pneumonia.American journal of respiratory cell and molecular biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Fengying TangCenter for Lung Biology, the University of Washington at South Lake Union, Seattle, WA, USA; Department of Comparative Medicine, University of Washington, Seattle, WA, USA. Electronic address: ftang27@uw.edu.
Stephen R ReevesCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, WA, USA; Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.
Jourdan E BruneCenter for Lung Biology, the University of Washington at South Lake Union, Seattle, WA, USA; Department of Comparative Medicine, University of Washington, Seattle, WA, USA.
Mary Y ChangCenter for Lung Biology, the University of Washington at South Lake Union, Seattle, WA, USA; Department of Comparative Medicine, University of Washington, Seattle, WA, USA.
Christina K ChanCenter for Lung Biology, the University of Washington at South Lake Union, Seattle, WA, USA; Department of Comparative Medicine, University of Washington, Seattle, WA, USA.
Peter WaldronCenter for Lung Biology, the University of Washington at South Lake Union, Seattle, WA, USA; Department of Comparative Medicine, University of Washington, Seattle, WA, USA.
Sheona P DrummondWelcome Centre for Cell-Matrix Research, University of Manchester, Manchester, UK; Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Caroline M MilnerFaculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
Kimberly M AlongeDepartment of Medicinal Chemistry, University of Washington, Seattle, WA, USA.
Stavros GarantziotisDivision of Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
Anthony J DayWelcome Centre for Cell-Matrix Research, University of Manchester, Manchester, UK; Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
William A AltemeierCenter for Lung Biology, the University of Washington at South Lake Union, Seattle, WA, USA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
Charles W FrevertCenter for Lung Biology, the University of Washington at South Lake Union, Seattle, WA, USA; Department of Comparative Medicine, University of Washington, Seattle, WA, USA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
University of Washington · USManchester Academic Health Science Centre · GBNational Institute of Environmental Health Sciences · USSeattle Children's Hospital · US

Funding

The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue InjuryZIAES102605 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI GARANTZIOTIS, STAVROS · 2009 to 2025
$22.6M
Regulation of Allergen-Induced Airway Pathophysiology by VersicanR01AI130280 · NIAID · UNIVERSITY OF WASHINGTON · PI FREVERT, CHARLES WAYNE, HALLSTRAND, TEAL S · 2019 to 2023
$3.8M
Impact of versican deficiency on the innate immune response to influenza virusR01AI136468 · NIAID · UNIVERSITY OF WASHINGTON · PI ALTEMEIER, WILLIAM A, FREVERT, CHARLES WAYNE · 2018 to 2022
$3.1M
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopmentDP2AI171150 · NIAID · UNIVERSITY OF WASHINGTON · PI Kimberly Michele Alonge · 2023 to 2026
$2.0M
PDGFR-beta+ stromal cells as critical regulators of immune response to tissue injuryR01HL122895 · NHLBI · UNIVERSITY OF WASHINGTON · PI ALTEMEIER, WILLIAM A · 2015 to 2018
$1.7M
Airway epithelial regulation of fibroblast hyaluronan and versican production in asthmatic airway inflammationK08HL135266 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI REEVES, STEPHEN R · 2017 to 2021
$812k
Altered hyaluronan deposition by bronchial epithelial cells contributes to inflammation during respiratory syncytial virus infectionR03HL156916 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI REEVES, STEPHEN R · 2022 to 2023
$189k
NHLBI NIH HHS K08 HL135266NHLBI NIH HHS R03 HL156916NIAID NIH HHS DP2 AI171150NIAID NIH HHS R01 AI130280NIAID NIH HHS R01 AI136468NIAID NIH HHS R01HL122895NIH HHS ES102605NIH HHS ES103342NIH HHS K08HL135266Versus Arthritis 22277
6 · The paper itself

Abstract

The inter-alpha-trypsin inhibitor (IαI) complex is composed of the bikunin core protein with a single chondroitin sulfate (CS) attached and one or two heavy chains (HCs) covalently linked to the CS chain. The HCs from IαI can be transferred to hyaluronan (HA) through a TNFα-stimulated gene-6 (TSG-6) dependent process to form an HC•HA matrix. Previous studies reported increased IαI, HA, and HC•HA complexes in mouse bronchoalveolar lavage fluid (BALF) post-influenza infection. However, the expression and incorporation of HCs into the HA matrix of the lungs during the clinical course of influenza A virus (IAV) infection and the biological significance of the HC•HA matrix are poorly understood. The present study aimed to better understand the composition of HC•HA matrices in mice infected with IAV and how these matrices regulate the host pulmonary immune response. In IAV infected mice bikunin, HC1-3, TSG-6, and HAS1-3 all show increased gene expression at various times during a 12-day clinical course. The increased accumulation of IαI and HA was confirmed in the lungs of infected mice using immunohistochemistry and quantitative digital pathology. Western blots confirmed increases in the IαI components in BALF and lung tissue at 6 days post-infection (dpi). Interestingly, HCs and bikunin recovered from BALF and plasma from mice 6 dpi with IAV, displayed differences in the HC composition by Western blot analysis and differences in bikunin's CS chain sulfation patterns by mass spectrometry analysis. This strongly suggests that the IαI components were synthesized in the lungs rather than translocated from the vascular compartment. HA was significantly increased in BALF at 6 dpi, and the HA recovered in BALF and lung tissues were modified with HCs indicating the presence of an HC•HA matrix. In vitro experiments using polyinosinic-polycytidylic acid (poly(I:C)) treated mouse lung fibroblasts (MLF) showed that modification of HA with HCs increased cell-associated HA, and that this increase was due to the retention of HA in the MLF glycocalyx. In vitro studies of leukocyte adhesion showed differential binding of lymphoid (Hut78), monocyte (U937), and neutrophil (dHL60) cell lines to HA and HC•HA matrices. Hut78 cells adhered to immobilized HA in a size and concentration-dependent manner. In contrast, the binding of dHL60 and U937 cells depended on generating a HC•HA matrix by MLF. Our in vivo findings, using multiple bronchoalveolar lavages, correlated with our in vitro findings in that lymphoid cells bound more tightly to the HA-glycocalyx in the lungs of influenza-infected mice than neutrophils and mononuclear phagocytes (MNPs). The neutrophils and MNPs were associated with a HC•HA matrix and were more readily lavaged from the lungs. In conclusion, this work shows increased IαI and HA accumulation and the formation of a HC•HA matrix in mouse lungs post-IAV infection. The formation of HA and HC•HA matrices could potentially create specific microenvironments in the lungs for immune cell recruitment and activation during IAV infection.

Indexed as

Alpha-GlobulinsInfluenza, HumanOrthomyxoviridaeAnimalsChondroitin SulfatesDisease ProgressionHumansHyaluronic AcidImmunity, InnateLungMiceAlpha-GlobulinsChondroitin SulfatesHyaluronic Acidinter-alpha-inhibitorExtracellular matrixHyaluronanInfluenza infectionIαILeukocyte adhesionLung inflammation

Identifiers

PMID38232913
PMCPMC13340032
OpenAlexW4390887165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.